Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

Sally Hopewell and John Christianson

Sally works within OCTRU as Professor of Clinical Trials and Evidence Synthesis. She is involved in leading the design and delivery of clinical trials within the OCTRU portfolio. She is also co-chief investigator on several NIHR funded trials for interventions for people with shoulder pain and impaired shoulder function. Her key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews.  

On receiving the award, Sally said “I am honoured and proud to receive this award and title Professor as part of this year’s Recognition of Distinction exercise. 

To me, this award shows recognition of the importance of conducting high quality trial methodology research and how it can be used to inform the design, conduct and reporting of future clinical trials; such as those carried out by the Oxford Clinical Trials Research Unit (OCTRU) and Centre for Statistics in Medicine (CSM).  

I am very grateful of the invaluable support I have received during my academic career and also pleased to add to the increasing number of female Professors within the Medical Sciences Division. I hope to inspire and encourage others to pursue a career in trial methodology research.”   

John is Professor and CRUK Senior Research Fellow in the Oppermann GroupHis research investigates the fundamental mechanisms and effects of cellular stress on cancers and many other diseases. His work explores new strategies for cancer intervention to prevent the progression of the disease.

He said “It is a great privilege to become a full professor at the University of Oxford. I owe this achievement to the hard work and tenacity of my DPhil students and post-docs, who have breathed the life into our research that enables it to flourish. 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.